The several potent inhaled anesthetics released for clinical use in the pas
t four decades have been halogenated ethers, and, with one exception, methy
l ethyl ethers. In the present report, we detail some structural and physic
al properties associated with anesthetic potency in 27 polyhalogenated meth
yl ethyl ethers. We obtained new data for 22 compounds. We wed response/non
response of rats to electrical stimulation of the tail as the anesthetic en
d point (i.e., we measured the minimum alveolar anesthetic concentration [M
AC]). For compounds that did not produce anesthesia when given alone (they
only produced excitation/convulsions), we studied MAC by additivity studies
with desflurane. We obtained MAC values for 20 of 22 of the studied ethers
, which gave products of MAC x oil/gas partition coefficient ranging from 1
.27 to 18.8 atm, compared with a product of 1.82 +/- 0.56 atm for conventio
nal inhaled anesthetics. Despite solubilities in olive oil and application
of partial pressures predicted by the Meyer-Overton hypothesis to provide a
nesthesia, 2 of 22 ethers (CCIF2OCCIFCF3 and CCIF2OCF2CCIF2) had no anesthe
tic (immobilizing) effect when given alone, did not decrease the anesthetic
requirement for desflurane, and had excitatory properties when administere
d alone. As with other inhaled anesthetics, anesthetic potency seemed to co
rrelate with both polar and nonpolar properties. These ethers, representing
structural analogs of currently used clinical volatile anesthetics, may be
useful in identifying and understanding the mechanisms by which inhaled an
esthetics act. Implications: The several potent, inhaled, polyhalogenated m
ethyl ethyl ether anesthetics released for clinical use in the past four de
cades seem to have specific useful characteristics that set them apart from
other methyl ethyl ethers. Properties of this class of compounds have impl
ications for the future development of anesthetics and the mechanisms by wh
ich they act.